Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides

Exclusion Criteria

• •Pregnant or breast-feeding females
• •Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data
• •Patients diagnosed with Sezary Syndrome. Sezary Syndrome is equivalent to mycosis fungoides that develops to Stage IVA/B with B2 (high blood tumor burden) involvement, and as such requires a more aggressive treatment regimen than Valchlor or TSEBT.
• •Patients who do not have their disease downgrade to stage IA or IB 30 days following low dose TSEBT.
• •Underlying medical condition including unstable cardiac disease, or other serious illness that would impair the ability of the patient to undergo treatment
• •Minimum 3 weeks since prior systematic treatment or phototherapy
• •Decisionally-impaired individuals, prisoners, and vulnerable populations